CoChat
Sign Up
Cited by 115

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

A large scale multivariate parallel ICA method reveals novel imaging–genetic relationships for Alzheimer's disease in the ADNI cohort

Meda, Shashwath A., Narayanan, Balaji, Liu, Jingyu, Perrone-Bizzozero, Nora I., Stevens, Michael C., Calhoun, Vince D., Glahn, David C., Shen, Li, Risacher, Shannon L., Saykin, Andrew J., Pearlson, Godfrey D.·2012·NeuroImage
DOI 10.1016/j.neuroimage.2011.12.076PMC PMC3312985
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuroimage.2011.12.076

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 53

  1. Bamburg, 2009, Cytoskeletal pathologies of Alzheimer disease, Cell Motil. Cytoskeleton, 66, 635, 10.1002/cm.20388 · DOI
  2. Bareiss, 2010, Delta-catenin/NPRAP: a new member of the glycogen synthase kinase-3beta signaling complex that promotes beta-catenin turnover in neurons, J. Neurosci. Res., 88, 2350, 10.1002/jnr.22414 · DOI
  3. Calkins, 2007, The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration, Schizophr Bull, 33, 33, 10.1093/schbul/sbl044 · DOI
  4. Calhoun, 2009, A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data, Neuroimage, 45, S163, 10.1016/j.neuroimage.2008.10.057 · DOI
  5. Dominguez, 2009, Actin filament nucleation and elongation factors—structure–function relationships, Crit. Rev. Biochem. Mol. Biol., 44, 351, 10.3109/10409230903277340 · DOI
  6. Eccles, 2010, The influence of common polymorphisms on breast cancer, Cancer Treat. Res., 155, 15, 10.1007/978-1-4419-6033-7_2 · DOI
  7. Eikelenboom, 2006, The significance of neuroinflammation in understanding Alzheimer's disease, J. Neural. Transm., 113, 1685, 10.1007/s00702-006-0575-6 · DOI
  8. Gallo, 2007, Tau is actin up in Alzheimer's disease, Nat. Cell Biol., 9, 133, 10.1038/ncb0207-133 · DOI
  9. Gandhi, 2010, Genome-wide association studies: the key to unlocking neurodegeneration?, Nat. Neurosci., 13, 789, 10.1038/nn.2584 · DOI
  10. Gatz, 2006, Role of genes and environments for explaining Alzheimer disease, Arch. Gen. Psychiatry, 63, 168, 10.1001/archpsyc.63.2.168 · DOI · Paper page
  11. Grupe, 2007, Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants, Hum. Mol. Genet., 16, 865, 10.1093/hmg/ddm031 · DOI · Paper page
  12. Guerreiro, R.J., Gustafson, D.R., Hardy, J., 2010. The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol. Aging Epub ahead of print, http://dx.doi.org/10.1016/j.neurobiolaging.2010.03.025. · DOI · Paper page
  13. He, 2005, GGA proteins mediate the recycling pathway of memapsin 2 (BACE), J. Biol. Chem., 280, 11696, 10.1074/jbc.M411296200 · DOI
  14. Hollingworth, 2011, Alzheimer's disease genetics: current knowledge and future challenges, Int. J. Geriatr. Psychiatry, 26, 793, 10.1002/gps.2628 · DOI
  15. Jack, 2010, Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative, Alzheimers Dement., 6, 212, 10.1016/j.jalz.2010.03.004 · DOI
  16. Jack, 2010, Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease, Brain, 133, 3336, 10.1093/brain/awq277 · DOI · Paper page
  17. Jagannathan, 2010, Genetic associations of brain structural networks in schizophrenia: a preliminary study, Biol. Psychiatry, 68, 657, 10.1016/j.biopsych.2010.06.002 · DOI
  18. Jurgensen, 2010, Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease, J. Mol. Neurosci., 40, 221, 10.1007/s12031-009-9237-0 · DOI
  19. Kagami, 2008, Identification and biochemical characterization of the SLC9A7 interactome, Mol. Membr. Biol., 25, 436, 10.1080/09687680802263046 · DOI
  20. Kolev, 2009, Implication of complement system and its regulators in Alzheimer's disease, Curr. Neuropharmacol., 7, 1, 10.2174/157015909787602805 · DOI
  21. Koncina, 2007, Role of semaphorins during axon growth and guidance, Adv. Exp. Med. Biol., 621, 50, 10.1007/978-0-387-76715-4_4 · DOI
  22. Kostiuk, 2010, Alteration of calcium signaling as one of the mechanisms of Alzheimer's disease and diabetic polyneuropathy, Fiziol. Zh., 56, 130, 10.15407/fz56.04.130 · DOI
  23. Ku, 2011, The pursuit of genome-wide association studies: where are we now?, J. Hum. Genet., 55, 195, 10.1038/jhg.2010.19 · DOI
  24. LaFerla, 2002, Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease, Nat. Rev. Neurosci., 3, 862, 10.1038/nrn960 · DOI
  25. Lee, 2010, The phosphoinositide 3-phosphatase MTMR2 interacts with PSD-95 and maintains excitatory synapses by modulating endosomal traffic, J. Neurosci., 30, 5508, 10.1523/JNEUROSCI.4283-09.2010 · DOI
  26. Li, 2006, Mutations of presenilin genes in dilated cardiomyopathy and heart failure, Am. J. Hum. Genet., 79, 1030, 10.1086/509900 · DOI
  27. Lin, 2005, Secretory carrier membrane proteins interact and regulate trafficking of the organellar (Na+, K+)/H+ exchanger NHE7, J. Cell Sci., 118, 1885, 10.1242/jcs.02315 · DOI
  28. Lin, 2006, Parsing the genetic heterogeneity of chromosome 12q susceptibility genes for Alzheimer disease by family-based association analysis, Neurogenetics, 7, 157, 10.1007/s10048-006-0047-z · DOI
  29. Liu, 2008, A parallel independent component analysis approach to investigate genomic influence on brain function, IEEE Signal Process. Lett., 15, 413, 10.1109/LSP.2008.922513 · DOI
  30. Lugtenberg, 2006, ZNF674: a new kruppel-associated box-containing zinc-finger gene involved in nonsyndromic X-linked mental retardation, Am. J. Hum. Genet., 78, 265, 10.1086/500306 · DOI
  31. Marks, 2010, BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis, Neurochem. Res., 35, 181, 10.1007/s11064-009-0054-1 · DOI
  32. Mattson, 2003, Neuronal and glial calcium signaling in Alzheimer's disease, Cell Calcium, 34, 385, 10.1016/S0143-4160(03)00128-3 · DOI
  33. Meda, 2010, A pilot multivariate parallel ICA study to investigate differential linkage between neural networks and genetic profiles in schizophrenia, Neuroimage, 53, 1007, 10.1016/j.neuroimage.2009.11.052 · DOI
  34. Meunier, 2009, Pivotal role of translokin/CEP57 in the unconventional secretion versus nuclear translocation of FGF2, Traffic, 10, 1765, 10.1111/j.1600-0854.2009.00985.x · DOI
  35. Ohgaki, 2008, Cell surface levels of organellar Na+/H+ exchanger isoform 6 are regulated by interaction with RACK1, J. Biol. Chem., 283, 4417, 10.1074/jbc.M705146200 · DOI
  36. Osterfield, 2008, Interaction of amyloid precursor protein with contactins and NgCAM in the retinotectal system, Development, 135, 1189, 10.1242/dev.007401 · DOI
  37. Pimplikar, 2010, Amyloid-independent mechanisms in Alzheimer's disease pathogenesis, J. Neurosci., 30, 14946, 10.1523/JNEUROSCI.4305-10.2010 · DOI
  38. Ramaswamy, 2010, Developmental disability: duplication of zinc finger transcription factors 673 and 674, Pediatr. Neurol., 43, 209, 10.1016/j.pediatrneurol.2010.04.016 · DOI
  39. Saxena, 2010, Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge, Nat. Genet., 42, 142, 10.1038/ng.521 · DOI
  40. Saykin, 2010, Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: genetics core aims, progress, and plans, Alzheimers Dement., 6, 265, 10.1016/j.jalz.2010.03.013 · DOI · Paper page
  41. Seshadri, 2010, Genome-wide analysis of genetic loci associated with Alzheimer disease, JAMA, 303, 1832, 10.1001/jama.2010.574 · DOI · Paper page
  42. Shen, 2010, Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort, Neuroimage, 53, 1051, 10.1016/j.neuroimage.2010.01.042 · DOI
  43. Smith, 2010, Neuroimaging through the course of Alzheimer's disease, J. Alzheimers Dis., 19, 273, 10.3233/JAD-2010-1217 · DOI
  44. Stieber, 1996, In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic, Am. J. Pathol., 148, 415
  45. Strittmatter, 1993, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. U. S. A., 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
  46. Terni, 2010, Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of Alzheimer's disease pathology, Brain Pathol., 20, 222, 10.1111/j.1750-3639.2009.00266.x · DOI · Paper page
  47. Thaker, 2008, Psychosis endophenotypes in schizophrenia and bipolar disorder, Schizophr Bull, 34, 720, 10.1093/schbul/sbn055 · DOI
  48. Traynor, 2010, Nature versus nurture: death of a dogma, and the road ahead, Neuron, 68, 196, 10.1016/j.neuron.2010.10.002 · DOI
  49. Urcelay, 2001, Enhanced proliferation of lymphoblasts from patients with Alzheimer dementia associated with calmodulin-dependent activation of the Na+/H+ exchanger, Neurobiol. Dis., 8, 289, 10.1006/nbdi.2000.0381 · DOI
  50. van Es, 2009, Alzheimer's disease beyond APOE, Nat. Genet., 41, 1047, 10.1038/ng1009-1047 · DOI
  51. Villain, 2010, Neuroimaging in Alzheimer's disease: a synthesis and a contribution to the understanding of physiopathological mechanisms, Biol Aujourdhui, 204, 145, 10.1051/jbio/2010010 · DOI
  52. Walker, 2008, Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease, Microvasc. Res., 75, 411, 10.1016/j.mvr.2007.10.004 · DOI
  53. Yang, 2008, Unbiased screening for transcriptional targets of ZKSCAN3 identifies integrin beta 4 and vascular endothelial growth factor as downstream targets, J. Biol. Chem., 283, 35295, 10.1074/jbc.M806965200 · DOI

Cited by

Sorted by citations

Metadata

Authors
Meda, S. A., Narayanan, B., Liu, J., Perrone-Bizzozero, N. I., Stevens, M. C., Calhoun, V. D., Glahn, D. C., Shen, L., Risacher, S. L., Saykin, A. J., & Pearlson, G. D.
Venue
NeuroImage
Publisher
Elsevier BV
Published
2012-04
Volume
60
Issue
3
Pages
1608-1621
ISSN
1053-8119
DOI
10.1016/j.neuroimage.2011.12.076
PMC
PMC3312985
Cited by
115
References
9
Language
en
Licence
Funders
  • Eli Lilly and Company
  • Siemens AG
  • Welch Allyn Inc.
  • NIH (R01 CA101318, R01 AG19771, RC2 AG036535, P30 AG10133–18S1, U01 AG032984, P30 AG010129, K01 AG030514, U01 AG024904)
  • Indiana Economic Development Corporation (IEDC #87884)
  • Foundation for the NIH (ROIEB005846)
  • Alzheimer's Disease Neuroimaging Initiative (ADNI)
  • National Institute on Aging
  • National Institute of Biomedical Imaging and Bioengineering
  • Abbott
  • Alzheimer's Association
  • Alzheimer's Drug Discovery Foundation
  • Amorfix Life Sciences Ltd
  • AstraZeneca
  • Bayer HealthCare
  • BioClinica, Inc
  • Biogen Idec Inc
  • Bristol-Myers Squibb Company
  • Eisai Inc
  • Elan Pharmaceuticals Inc
  • F. Hoffmann-La Roche Ltd.
  • Genentech, Inc.
  • GE Healthcare
  • Innogenetics, N.V
  • Janssen Alzheimer Immunotherapy Research & Development, LLC
  • Johnson & Johnson Pharmaceutical Research & Development LLC.
  • Medpace, Inc
  • Merck & Co., Inc
  • Meso Scale Diagnostics, LLC
  • Novartis Pharmaceuticals Corporation
  • Pfizer Inc
  • Servier
  • Synarc Inc
  • Takeda Pharmaceutical Company
  • Canadian Institutes of Health Research
  • Foundation for the National Institutes of Health
  • Northern California Institute for Research and Education
  • Dana Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review